Tyra Biosciences, Inc. logo

Tyra Biosciences, Inc.

NASDAQ:TYRA

Overview | Financials
Company Name Tyra Biosciences, Inc.
Symbol TYRA
Currency USD
Price 14
Market Cap 740,205,550
Dividend Yield 0%
52-week-range 11.24 - 29.6
Industry Biotechnology
Sector Healthcare
CEO Dr. Todd Harris Ph.D.
Website https://www.tyra.bio

An error occurred while fetching data.

About Tyra Biosciences, Inc.

Tyra Biosciences, Inc., a preclinical-stage biopharmaceutical company, focuses on developing therapies to overcome tumor resistance and enhance outcomes for patients with cancer. Its lead product candidate is TYRA-300, a selective inhibitor of fibroblast growth factor receptor (FGFR)3 for the treatment of muscle invasive bladder cancer. The company is also developing

Related Stocks

Esperion Therapeutics, Inc. logo

Esperion Therapeutics, Inc.

ESPR

2.19 USD

Monte Rosa Therapeutics, Inc. logo

Monte Rosa Therapeutics, Inc.

GLUE

6.93 USD

Belite Bio, Inc logo

Belite Bio, Inc

BLTE

64.12 USD

Regencell Bioscience Holdings Limited logo

Regencell Bioscience Holdings Limited

RGC

4.92 USD

Arcellx, Inc. logo

Arcellx, Inc.

ACLX

75.54 USD

Inotiv, Inc. logo

Inotiv, Inc.

NOTV

4.08 USD

Kodiak Sciences Inc. logo

Kodiak Sciences Inc.

KOD

8.65 USD

MeiraGTx Holdings plc logo

MeiraGTx Holdings plc

MGTX

6.15 USD

Viridian Therapeutics, Inc. logo

Viridian Therapeutics, Inc.

VRDN

19.03 USD

Financials

Numbers are in millions USD

Numbers are in millions USD